RecruitingNCT06805734
Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
Studying PTEN hamartoma tumor syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Enrollment
- 50 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2024 – 2029
Study locations (1)
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
Collaborators
Azienda Ospedaliera Sant'Anna · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06805734 on ClinicalTrials.govOther trials for PTEN hamartoma tumor syndrome
Additional recruiting or active studies for the same condition.